Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with abdominal wall block for recovery after laparoscopic colorectal cancer surgery
ChiCTR2000039295Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in colorectal cancer (CRC) (3 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoints: Quality of recovery-40 (QoR-40) score and Neutrophil-to-lymphocyte ratio (NLR). Started Nov 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000039295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039295.